Skip to main content
Terug
Watch Compare

Marpai, Inc.

Datakwaliteit: 100%
MRAI
OTC Services Health Services
€ 0,25
▲ € 0,01 (3,31%)
Marktkapitalisatie: 6,32 M
Prijs
€ 0,25
Marktkapitalisatie
6,32 M
Dagbereik
€ 0,24 — € 0,30
52-Weeksbereik
€ 0,22 — € 1,78
Volume
66.774
Openen € 0,28
50D / 200D Gem.
€ 0,49
49,31% below
50D / 200D Gem.
€ 1,00
74,97% below

Quick Summary

Belangrijkste Punten

Revenue grew 6,20% annually over 5 years — modest growth
Negative free cash flow of -7,45 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 41,96%

Groei

Revenue Growth (5Y)
6,20%
Onder sectorgemiddelde (19,14%)
Revenue (1Y)-35,76%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-91,50%
Op. Margin-74,88%

Veiligheid

Debt / Equity
N/A
Current Ratio0,53
Interest Coverage-4,19

Waardering

PE (TTM)
-0,38
Onder sectorgemiddelde (-0,01)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (20 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 0,0
P/B — 3,1
ROE % — -1,5
Net Margin % -91,5 -0,3
Rev Growth 5Y % 6,2 19,1
D/E — 1,0

All Fundamental Metrics
Growth
Revenue Growth (1Y) -35,76% Revenue Growth (3Y) -30,21%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 6,20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 18,10 M Net Income (TTM) -16,56 M
ROE N/A ROA -139,08%
Gross Margin N/A Operating Margin -74,88%
Net Margin -91,50% Free Cash Flow (TTM) -7,45 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,53
Interest Coverage -4,19 Asset Turnover 1,52
Working Capital -10,70 M Tangible Book Value -33,35 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,38 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,35
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -117,87%
Market Cap 6,32 M Enterprise Value 24,83 M
Per Share
EPS (Diluted TTM) -0,95 Revenue / Share 0,72
FCF / Share -0,29 OCF / Share -0,29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 45,01%
SBC-Adj. FCF -9,28 M Growth Momentum -41,96

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 18,10 M 28,17 M 37,16 M 24,34 M 14,23 M
Net Income -16,56 M -22,09 M -28,75 M -26,47 M -15,98 M
EPS (Diluted) -0,95 -1,92 -4,14 -1,31 -1,59
Gross Profit — — — — —
Operating Income -13,55 M -22,09 M -27,98 M -26,96 M -15,86 M
EBITDA — — — — —
R&D Expenses 7.000,0 29.000,0 1,31 M 3,71 M 1,73 M
SG&A Expenses — — — — —
D&A 381.000,0 2,26 M 3,90 M 3,54 M 1,96 M
Interest Expense 3,23 M 2,71 M 1,53 M 266.778,0 427.178,0
Income Tax -1,19 M -1,19 M -290.138,0 -521.132,0 -150.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10,90 M 12,88 M 31,68 M 49,95 M 44,20 M
Total Liabilities 43,47 M 40,59 M 45,12 M 43,82 M 14,49 M
Shareholders' Equity -32,56 M -27,71 M -13,44 M 6,13 M 29,71 M
Total Debt 30,40 M 26,80 M 20,00 M 20,20 M 3,00 M
Cash & Equivalents 133.000,0 764.000,0 1,15 M 13,76 M 19,18 M
Current Assets 10,34 M 11,90 M 17,08 M 26,54 M 26,99 M
Current Liabilities 25,69 M 18,98 M 20,84 M 17,36 M 11,15 M